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Twenty-seven Protein Polymorphisms by
Two-Dimensional Electrophoresis of Serum,
Erythrocytes, and Fibroblasts in Two Pedigrees
DAVID GOLDMAN,' LYNN R. GOLDIN,2 P. RATHNAGIRI,' STEPHEN J. O'BRIEN,3
JANICE A. EGELAND,4 AND CARL R. MERRIL2
SUMMARY
Twenty-seven independent polymorphic loci were detected by two-
dimensional electrophoresis (2DE) of serum, erythrocytes, and
fibroblasts in two large families and analyzed for linkage to classical
genetic markers. We detected seven serum, four erythrocyte, and 17
fibroblast protein loci that exhibited charge variation in these two
families and in a sample of unrelated individuals. The genetic basis of
protein variants was confirmed by quantitative gene-dosage depen-
dence and by conformance to Mendelian transmission in the two
families, except for four rare variants for which transmission analysis
was not possible. Linkage analysis demonstrated that each of the
variants represent products of independent loci, with the exception of
erythrocyte locus (RBC4), which we also detected in fibroblasts
(NC27). Two allozyme polymorphisms, glyoxalase-l (GLOJ) and
phosphoglucomutase-3 (PGM3) were specifically identified here based
on genotypic concordance and molecular mass. Unknown fibroblast
protein (NC22) may be linked to apolipoprotein E (lod score = 2.8 at
Om = Of = 0), while a serum protein locus (SERI) may be linked to
alpha-haptoglobin (lod score = 2.54 at Om = .20, Of = .01). Six of
seven polymorphic serum loci were previously located on two-
dimensional gels: alpha-1 antitrypsin (P1), Gc-globulin (GC), alpha-2
HS glycoprotein (HSGA), alpha-haptoglobin (HP), and two apolipo-
proteins (APOE and APOA4). Six of 17 polymorphisms detected in
fibroblasts were positionally identical to polymorphic loci seen in lym-
phocytes. These studies indicate a minimum level of average protein
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charge heterozygosity of approximately 2.2% for the most predomi-
nant human cellular proteins and of 5.6% for the most predominant
proteins of serum.
INTRODUCTION
The two-stage electrophoresis method of O'Farrell [1] is effective for detection
of protein charge mobility variants [2] including most protein polymorphic
variants detectable by one-dimensional electrophoresis (IDE) [3]. Among 186
human lymphocyte proteins, we described 19 independent polymorphic sys-
tems, each consisting of 2-3 allelic charge variants that displayed codominant
expression in heterozygotes and strict genotypic concordance in identical twins
and replicate samples [4, 5]. Several of these variant human proteins were
positionally identical to polymorphic loci independently reported by Hama-
guchi et al. [6].
The extent of protein charge genetic variation was originally reported to be
rather low when 2DE was first applied to human cellular proteins. Average per
locus heterozygosities of less than 1% were estimated by McConkey et al. [7],
Walton et al. [8], and Smith et al. [9], as compared to 6.3% for 104 allozyme loci
[10]. However, several recent studies have revised upward estimates of aver-
age protein heterozygosity by 2DE. We recently found 19 polymorphic loci
among 186 loci of human lymphoblast, for a minimum average heterozygosity
of 2.4% [5]. Rosenblum et al. [11] estimated that the average heterozy-
gosity of serum loci detected by 2DE is 6.2% and that the average heterozygos-
ity of erythrocyte loci is 3.1% [12].
We report here population frequencies in a small group of unrelated individ-
uals and linkage relationships in two large families of 27 independent protein
charge polymorphisms detected in electropherograms of human serum, eryth-




Serum and erythrocytes (washed three times with phosphate-buffered saline [PBS]
were obtained from 2 ml of heparinized venous blood. For family 1, skin fibroblasts
were obtained from primary cultures of forearm 3-mm punch biopsies. Family 2 is
Amish pedigree 110 under extensive study by one of us (J. A. E.). For this family, 35
skin fibroblast lines were obtained from the Institute for Medical Research (IMR),
Camden, N.J. (IMR family 884). As part of our population sample, 21 fibroblast lines
were obtained from the IMR. These were normal lines GM41, GM288, GM321, GM323,
GM497, GM726, GM964, GM967, GM1652, GM1653, GM1717, GM2912, GM3234,
GM3377, GM3651, and GM3652 and Duchenne's lines GM2339, GM3429, GM3604,
GM3781, and GM4327.
For radiolabeling, fibroblasts were grown to confluence in EMEM with 15% FBS and
2 mM glutamine, trypsinized (0.02% trypsin in PBS with 0.02% EDTA), and resus-
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pended in growth medium. Cells were seeded at a 1:1 split into microwells at 10,000
cells/well, incubated overnight, and washed with PBS. For labeling with [C14]leucine
(New England Nuclear, Boston, Mass., NEC-279E, 345 mCi/mmol), incubation was for
20 hrs in leucine-deficient EMEM with 15% dialyzed FBS, 2 mM glutamine, and 10
microcuries of ['4C]leucine/well. For labeling with [35S]methionine (New England Nu-
clear, NEG-009T, 1166.5 Ci/mmol), incubation was for 3 hrs in methionine-deficient
EMEM with 15% dialyzed FBS, 2 mM glutamine, and 100 microcuries of
[S35]methionine/well. Following labeling, monolayers were washed twice with PBS and
proteins were extracted with a sample solution containing 2% SDS, 2% ampholytes,
20% glycerol, 2% NP-40, and 5% mercaptoethanol.
Two-stage electrophoresis was carried out essentially according to O'Farrell [1]. For
isoelectric focusing (IEF) of fibroblast proteins, approximately 30 pRg of protein (500,000
dpm) extracted from the monolayers was run. Proteins extracted from 1.5,u of packed
cells and from 1.5,ul of serum were run for erythrocyte and serum IEF. Protein extracts
were made 8 M with urea, and IEF was for 20 hrs at 300-500 V in 5% polyacrylamide
tube gels that were prefocused for 30 min with 1.6% 5/7 ampholytes (Biorad, Richmond,
Calif.) and 0.4% 3/10 ampholytes. Voltage was increased to 1,000 V for the last hour.
Second-stage SDS-polyacrylamide gel electrophoresis was performed at 15-20 mA per
gel using 10% acrylamide slab gels that were 0.8-mm thick. Fibroblast proteins were
visualized after autoradiography (2 weeks exposure) using Kodak XAR-2 film. Erythro-
cyte and serum proteins were visualized by silver staining [13, 14].
Computerized densitometry was used to confirm the gene-dosage effect in heterozy-
gotes. To accomplish this, images were scanned using a high-resolution densitometer
(Optronics 1000HS) set at 200 microns resolution. Density measurements were taken
interactively using software written from DeAnza IP5000 and IP6400 array processors
and Dec 1100 series computers [4, 5].
Gene frequencies for the two-dimensional polymorphisms were calculated from a
sample of approximately 25 unrelated individuals that included controls and unrelated
spouses from family 1. No members of the Amish pedigree were included in this cal-
culation.
For family 1, ESD, GLOJ, PGMJ, PGM2, PGM3, ADA, and AK were determined in
the laboratory of S. J. O.; ADA, AK and PGM2 were not segregating in this family. For
family 2 (Amish study pedigree), phenotypes for red cell antigens, HLA, and allozyme
loci were typed. Red cell phenotypes at the ABO, Rh, MNS, K, Fy, Jk, Le, Lu, and P
loci were typed by Dr. L. Molthan at the Miller Memorial Blood Center (Bethlehem,
Pa.) using licensed sera. HLA typing was done by Dr. M. Dahlke at the American Red
Cross Blood Services (Philadelphia, Pa.) by means of the standard N.I.H. lymphocytox-
icity assay. Phenotypes for red cell enzymes and proteins [adenylate kinase (AK),
adenosine deaminase (ADA), 6-phosphogluconate dehydrogenase (PGD), phospho-
glucomutase-1 (PGMI), phosphoglycollate phosphatase (PGP), galactose-l-phosphate
uridyltransferase (GALT), acid phosphatase (ACP), glutamate pyruvate transaminase
(GPT), esterase D (ESD), glyoxalase-l (GLOI), haptoglobin (HP), transferrin (TF),
group specific component (GC), complement-third component (C3), amylase 2 (AM Y2),
alpha,-antitrypsin (PI), and properdin factor B (BF)] were determined in the laboratory
of Dr. R. S. Sparkes at UCLA. ABO, K, Le, Lu, Ak, ADA, AMY2, and BF were not
segregating in family 2. Lod scores were calculated using the computer program LIPED
[15] to examine the linkage relationships between pairs of known loci and unknown 2DE
loci and between all pairs of unknown 2DE loci.
RESULTS
Two-dimensional electrophoresis of serum, erythrocytes, and fibroblasts
from more than 100 individuals resolved 27 independent protein polymor-
phisms. These variants and their allelic frequencies and gel map coordinates
are listed in table 1. Their locations are illustrated in figure 1 (fibroblast), figure
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TABLE I





OTHER DESIGNATION (kd) PI r p q
Fibroblast:
NC21 ........................ 47 5.10 ... .10 .90
NC22 . ............. 60 5.00 ... .06 .94
NC23 ........................ 62 5.35 .01 .98 .01
NC24 ........................ 63 5.60 ... .99 .01
NC25 ........................ 56 5.85 ... .98 .02
NC26 PGM3 ......... ....... 66 5.75 ... .75 .25
NC27 ........................ 28 5.65 ... .27 .73
NC28 . ............. 80 5.65 ... .93 .07
NC29 . ............. 93 5.60 ... .03 .97
NC30 . ............. 108 5.90 .76 .22 .02
NC31 ........................ 25 5.55 ... .02 .98
Fibroblast and lymphocyte:
NCI H37K ......... ....... 40 5.25 ... .72 .28
NC5 H49K ......... ....... 54 5.60 ... .75 .25
NC7 H40K ......... ....... 41 5.65 ... .30 .70
NCI13 ........................ 84 5.55 ... .12 .88
NC16 C31K ................. 31 5.10 ... .94 .06
NC18 . ............. 57 5.30 ... .97 .03
Lymphocyte:
NC2,3 ....................... 73 5.90 .01 .36 .63
NC4 H64K ......... ....... 66 5.20 ... .84 .16
NC6. ........................ 30 5.60 ... .39 .61
NC8 ......................... 118 6.00 ... .79 .21
NC9 ......................... 125 5.90 ... .27 .73
NC10 ESD .......... ........ 33 6.00 ... .11 .89
NC11 ........................ 24 5.90 ... .03 .97
NC 12 ........................ 54 5.50 ... .05 .95
NC14 C100K ................ 107 5.60 ... .79 .21
NC15 ........................ 71 5.70 ... .02 .98
NC17 . ............. 46 5.90 ... .11 .89
NC19 ........................ 43 5.40 ... .92 .08
NC20 . ............. 39 5.90 ... .02 .98
Erythrocytes:
RBCI GLO ......... ........ 20 ... ... .53 .47
RBC2 . ............. 27 ... .06 .94
RBC3 . ............. 46 ... ... .04 .96
RBC4 (same as NC27) ......... ... ... ...
Serum:
SERI ....................... 33 ... ... .50 .50
APOE ....................... 28 ... .10 .83 .07
APOA4 ...................... 40 ... ... .92 .08
PI ........................... 52 ... ... .95 .05
HSGA ....................... 51 ... ... .73 .27
GC ........................ 53 ... ... .85 .15
HP ........................ 9, 16 ... .24* .16* .60*
NOTE: We have modified our nomenclature to designate the polymorphisms of nucleated cells as "NC" rather
than "NIMH." The no. of the locus follows the designation "NC." We have scored alleles M (acidic) and S
(basic) at the PI locus.
* These are published allele frequencies for HP.



















FIG. 2.-Silver-stained 2DE gel of human erythrocyte proteins to identify the positions of four
polymorphic systems. One of these (RBC ) has been identified as glyoxalase 1. Electrophoresis of
1.5 p.l of washed, packed erythrocytes was accomplished according to the procedure of O'Farrell
I1] with modifications as described in MATERIALS AND METHODS. Polymorphisms were initially
identified in a population of 80 individuals by the criteria that a discrete-charge-shifted variant
could be detected which in heterozygotes showed gene dosage so that the two electromorphs were
approximately equal in density when present in heterozygous individuals. Population allelic fre-
quencies, molecular weights, and pls are contained in table 1.
2 (erythrocyte), and figure 3 (serum). For comparative purposes, we also in-
clude in table 1 the 2DE polymorphisms detected in lymphocytes in previous
studies including studies done in our laboratory [4, 5, 16, 17]. Polymorphic loci
all showed a discrete shift in polypeptide charge in some individuals surveyed.
As an example, polymorphic fibroblast locus NC21 (47 kd, pl 5.1) is illustrated
in figure 4, in which the gel subregions from individuals homozygous acidic,
heterozygous, and homozygous basic are illustrated. A slight shift in apparent
molecular mass, frequently observed for charge-substituted variants [18],
sometimes occurred in addition to the charge mobility shift. Except for two
fibroblast polymorphisms, three polymorphic serum loci and a previously de-
FIG. 1. -Autoradiograms of human fibroblast proteins to identify the positions of 17 polymorphic
systems. One of these (NC26) has been identified as PGM3. Fibroblasts were isolated from 3-mm
diameter punch biopsies and were radiolabeled either for 3 hrs with 100 microcuries of ['5S]
methionine (A) or for 20 hrs with ['4C]leucine (B). Electrophoresis was accomplished according to
the procedure of O'Farrell [1] with modifications as described in MATERIALS AND METHODS. Polymor-
phisms were identified among 168 protein spots analyzed in a population of 41 individuals by the
criteria that a discrete-charge-shifted variant could be detected which in heterozygotes showed
gene dosage in both [14C] and [35S] autoradiograms so that the two electromorphs were approxi-
mately equal in density when present in heterozygous individuals. Population allelic frequencies,












FIG. 3.-Silver-stained 2DE gel of human serum proteins to identify the positions of SERI
(labeled "1"), six known polymorphic protein loci that were detected (open arrows), and a no. of
other known loci. Gels were prepared using 1.5 pAl of serum obtained from heparinized blood.
Electrophoresis was accomplished according to the procedure of O'Farrell [I] with modifications
as described in MATERIALS AND METHODS. Polymorphisms were initially identified in a population of
90 individuals by the criteria that a discrete-charge-shifted variant could be detected which in
heterozygotes showed gene dosage so that the two electromorphs were approximately equal in
density when present in heterozygous individuals. With respect to the HP polymorphism, there are
three alleles, two coding for lower molecular weight polypeptides designated HP al type (IF and
IS) and one coding for a higher molecular weight polypeptide designated as HP a2 type (2). This
particular individual is heterozygous for the 2 and IF alleles. The third allele, IS, is located basic to
prealbumin and at the same apparent molecular mass as HP-IF (see 1191). Population allelic
frequencies, molecular weights, and pls are contained in table 1.
scribed polymorphic locus of the lymphoblast, which show three or four al-
leles, these loci are bimorphic. Each of the protein polymorphisms was charac-
terized by quantitative gene-dosage dependence since heterozygotes expressed
approximately 50% of each allelic gene product (by densitometry) as compared
to the corresponding molecular form in the homozygote [5]. Protein variants
were transmitted in a Mendelian fashion in each system for which pedigree
segregation data was available, thereby confirming the genetic bases of the
polymorphisms.
In autoradiograms of fibroblasts labeled with [VS]methionine (fig. lA) or
[14C]leucine (fig. IB), 17 of 168 protein loci displayed a charge mobility variant.
Six of these (NC1, NC5, NC7, NC13, NCl6, and NC18) were positionally
identical to loci previously identified in two-dimensional electrophertograms of
lymphocytes [4, 5, 16, 17]. Although several proteins differed quantitatively in
their methionine-labeled vs. leucine-labeled autoradiographic intensities (fig.
904
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FIG. 4.-Gel subregions from [3'S]methionine fibroblast autoradiograms to illustrate the three
phenotypes observed for NC21 (47 kd. pl 5.1). From left to right, the basic homozygote. the
heterozygote, and the acidic homozygote are displayed. The major polypeptide at the lower right in
each panel is actin.
1A and B), all but one protein, NC16, were detected with either amino acid.
NC16 could be seen only using ['4C]leucine (fig. 1B).
Four polymorphic loci were detected among approximately 90 loci resolved
using silver-stained electropherograms of erythrocytes (fig. 2). RBC1 is D-014
and RBC4 is E-013 of Rosenblum et al. [12]. In addition, the positions of G6PD
(polymorphic in some populations) and of HPRT are indicated on this map.
In serum (fig. 3), most protein loci are visualized as series of polypeptide
spots that occur as a result of post-translational modifications such as the
addition of carbohydrate moieties [19]. Polymorphic charge variants, never-
theless, can be identified because they cause the shift of the entire series of
polypeptides. Seven polymorphic loci were detected among approximately 35
loci scored on silver-stained electrophertograms of serum (fig. 3). The identities
of six of these polymorphic loci (GC, PI, HSGA, APOE, APOA4, and HP)
have been described [19-21] and are indicated in figure 3. Gamma-fibrinogen
and APOA1 are known to show genetic variation [22. 23] but were mono-
morphic in our sample.
For linkage analysis, families 1 and 2 were chosen because they are both
large multigenerational pedigrees. Family 2 is especially useful because it con-
tains a number of large sibships and because it is gaining usage as a reference
pedigree for gene mapping [24]. Family 1 was informative for four classical
allozyme marker loci and for nine fibroblast, three erythrocyte, and seven
serum loci from 2D gels. Family 2 was informative for 19 classical marker loci
and for six fibroblast, two erythrocyte, and two serum loci from 2D gels. The
remaining 2DE loci were either not scorable or not segregating in the family.
Lod scores were calculated between pairs of known protein loci and unknown
2DE protein loci and among all pairs of unknown 2DE loci (table 2).
Several findings became evident from the linkage analysis. PGM3 and GLOI
showed phenotypic identity in a sample of 100 individuals (many of whom were
unrelated spouses) with 2DE loci NC26 (fibroblasts) and RBC I (erythrocytes).
The apparent molecular mass of GLOJ is 20 kilodaltons (kd) compared to a
reported molecular mass of 24 kd [25]. The apparent molecular mass of PGM3
is 66 kd compared to a reported molecular mass of 53 kd [25]. The errors
associated with molecular weight estimation by SDS gels are well within the
range of differences observed here. The complete concordances for these two
loci and the conformance of the molecular weight data point to the extremely




CLOSE LINKAGES EXCLUDED TO UNIDENTIFIED LocI
2DE LOCUS
CHROMOSOME MARKER NC7 NC21 NC23 NC27 NC30 NC31 SERI




ACP1 X X X X
3 ........ TF X X X
4 ........ MNS X X
GC X X X
6 ........ HLA X X X
GLOI X X X
PGM3 X
P
9 ......... GALT X
13 ........ ESD
14 ........ PI
16 ......... PGP X
HP X X X
19. C3
? . .GPT X X
NOTE: Linkage excluded when the lod score at 0% recombination was s - 2.0.
NC26 are the same protein. In addition, we observed complete phenotypic
identity betwen RBC4 and NC27. These loci can also be seen as positionally
identical on figures 1 and 2.
Two potential linkages between known loci and two additional 2DE loci were
found. NC22 may be linked to APOE (chromosome 19, lod score = 2.8 at Om =
Of = 0%). SERI, the only unknown polymorphic serum locus, may be linked to
HP (chromosome 16, lod = 2.54 at Om = .20, Of = .01). Finally, we excluded
linkage of some of the unknown fibroblast loci to known markers (table 2). The
significance of the two positive linkages should be interpreted with caution
because of the large number of tests that were done.
DISCUSSION
We detected 27 independent polymorphic loci by 2DE of serum, erythro-
cytes, and fibroblasts. Fourteen were previously detected by means of 2DE by
ourselves or others. Six of the 17 fibroblast polymorphisms are positionally
identical to polymorphic loci found in lymphocytes [4, 5], including four re-
ported independently by Hamaguchi et al. [6, 16]. These four are a 37-kd
polypeptide corresponding to NC1 (40 kd), a 64-kd polypeptide corresponding
to NC4 (66 kd), a 49-kd polypeptide corresponding to NC5 (54 kd), and a 40-kd
polypeptide corresponding to NC7 (41 kd). Kondo et al. [17] suggest that a
polymorphic lymphocyte polypeptide of molecular weight 100 kd [26] corre-
sponds to our NC14 and a polypeptide ofMW 31K corresponds to our NC 16.
An additional 13 potentially independent polymorphic loci have been identified
906
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in lymphocytes. Kondo et al. [27] found a 33-kd polypetide in cells that they
have identified as esterase-D. This probably corresponds to the locus, NC10O
that we find in lymphocytes but not in erythrocytes or fibroblasts because of the
pH gradient we employed in these studies. Here, we report the position of
PGM3 (NC26) in the fibroblast gel map and of GLOJ (RBC 1) in the erythrocyte
gel map. For the erythrocyte, Rosenblum et al. [121 independently reported six
polymorphic loci. Our RBCI corresponds positionally to their D-014 and RBC4
to their E-013. For serum, SERI is novel but the other six polymorphic loci
have been identified. These are PI [19], GC [19], HSGA [19], APOE [201, HP
[ 19], and APOA4 [21 ]. Variants of TF [19]. gamma fibrinogen [22], and APOA I
[23] are also detectable on 2DE gels of serum. A gamma fibrinogen polymor-
phism has been observed in a single Norwegian family. The apoA-I lipoprotein
variant (which we did not detect in this study) has a frequency of .008 in
Norwegians [23]. Rarer variants that have been identified by 2DE from extracts
of cells include nonmuscle tropomyosin [28], actin [29], and G6PD and HPRT
[30, 31]. In brain, genetic variants of myelin basic protein [32] and glial fibrillary
acidic protein [33] and the unknown locus PC-I Duarte [34] have been shown.
On a theoretical level, 2DE has for several years been recognized to be an
advance in the detection of protein charge polymorphism as it adequately re-
solves most charge variants [1, 2] and permits the simultaneous examination of
hundreds of loci on a single gel. The protein polymorphisms detected by 2DE
have generally been two-allele electrophoretic variants characterized by a sin-
gle charge shift and a gene-dosage effect in heterozygotes [4-6, 34]. The extent
of shift in charge position has been consistent with a single charge substitution
having occurred, being similar to the shift in charge position caused by pro-
cesses, such as phosphorylation, carbamylation, deamidation, or removal of a
sialic acid residue, which result in the loss or gain of a single charge. The extent
of the shift in charge position in the IEF gel has, in general, varied inversely
with molecular weight [1, 5]. Most allozyme variants detected by IDE are
probably resolved by 2DE [3].
On a practical level, the promise of 2DE for detecting protein charge genetic
variation resisted translation into reality. Several of the studies done within the
first 5 years after the method was published detected levels of average cellular
protein charge heterozygosity of less than 1% [7-9], leading to the conclusion
that 2DE was either not very efficient for detecting protein polymorphism or
that true rates of cellular protein heterozygosity were so low that surveys of
human cellular proteins with 2DE would not result in the discovery of a large
number of polymorphic loci.
Studies completed in the last 3 years have demonstrated that the level of
heterozygosity among the cellular proteins that can be surveyed by 2DE is
much greater than the levels found in these early studies. On the basis of our
survey of more than 160 human loci in both lymphocyte and fibroblast, we
conclude that cellular protein charge heterozygosity is approximately 2.2% and
that approximately 10% of loci are polymorphic (table 3). Rosenblum et al.
estimated heterozygosities of 3.1% for the human erythrocyte [12] and 2.0% for




SUMMARY OF POLYMORPHISMS IDENTIFIED IN THREE HUMAN TISSUES
No. loci No. Average
surveyed polymorphic heterozygosity
Fibroblasts ..... 168 17 .020
Lymphoblasts 186 19 .024
Serum .......... 40 7 .056
cause the number of loci scored may be smaller than realized (because of
multiple electrophoretic species that are the product of the same locus) and
because additional polymorphic loci (albeit with rarer variant alleles) may be
discovered as electropherograms are scrutinized more carefully and as the
populations surveyed are expanded. Heterozygosity might also be increased if
null alleles were scored. However, in this study we did not systematically
screen for null alleles. In addition, antibodies might be used to better visualize
loci whose gene products are present in smaller amounts.
For animals that show less allozyme polymorphic variation than the human,
such as the cheetah [36] and possibly the giant panda [37], the levels of cellular
protein heterozygosity with 2DE are greatly reduced, and for species with
higher variation such as drosophila, estimates from 2DE are also higher [38].
Taken together, these results indicate that levels of cellular protein heterozy-
gosity observable by 2DE are roughly proportional to and from one-third to
one-half the levels detected by allozyme electrophoresis.
On the other hand, compared to fibroblasts and lymphocytes, the level of
heterozygosity in serum proteins is higher, being similar to the rate of 6.3%
found by Harris for 104 allozyme loci [10]. Using 2DE, Rosenblum et al. [11]
found an average heterozygosity level of 6.2% for 20 randomly selected serum
protein loci. Here, we report a minimum heterozygosity of approximately 5.6%
for 40 serum loci. The finding that the predominant proteins of serum are more
polymorphic than those of cells suggests that cellular proteins may be under
selective pressures that mitigate against genetic variation.
According to the neutrality hypothesis, the distribution of heterozygosity
frequencies should be exponential [39]. The distribution of heterozygosities for
the 40 independent loci that we have identified in lymphocytes, fibroblasts,
erythrocytes, and serum is shown in figure 5. Apparently, the distribution is
bimodal and there are two classes of loci are represented: those that have very
common variant alleles and those that have less frequent variant alleles
(heterozygosity < 25%). This distribution resembles the survey of heterozygos-
ity indices for 43 allozyme loci by Harris et al. [40], except that in their study,
over 4,000 individuals were surveyed so that they were also able to screen for
very rare alleles. Selective mechanisms consistent with the observed excess of
loci with high heterozygosity include balanced selection and ecological niche
heterogeneity. However, other conditions such as population admixture could
also explain this excess.
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1ave rarer allele frequencies of greater than.s10. With respect to the usefulness
of these new markers for linkage studies, approximately 40% of these 40 mark-
ers are moderately informative for linkage according to the definition of Bot-
stein et al. [41 ]. Protein genetic variants identified by 2DE will be of use when it
is of advantage in population genetic or familial transmission studies to directly
observe gene products. This method also may be advantageous for the initial
screening of marker loci for linkage to a trait locus.
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